miR-200a Inhibits Tumor Proliferation by Targeting AP-2γ in Neuroblastoma Cells |
Gao, Shun-Li
(Department of pediatrics, The First Affiliated Hospital, University of South China)
Wang, Li-Zhong (Department of pediatrics, The First Affiliated Hospital, University of South China) Liu, Hai-Ying (Department of pediatrics, The First Affiliated Hospital, University of South China) Liu, Dan-Li (Department of pediatrics, The First Affiliated Hospital, University of South China) Xie, Li-Ming (Cancer Research Institute, University of South China, Key Laboratory of Cancer Cellular and Molecular Pathology of Hunan Provincial University) Zhang, Zhi-Wei (Cancer Research Institute, University of South China, Key Laboratory of Cancer Cellular and Molecular Pathology of Hunan Provincial University) |
1 | Adam L, Zhong M, Choi W, et al (2009). miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res, 15, 5060-72. DOI ScienceOn |
2 | Bai JX, Yan B, Zhao ZN, et al (2013). Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines. Endocrinology, 154, 635-45. DOI |
3 | Bracken CP, Gregory PA, Kolesnikoff N, et al (2008). A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res, 68, 7846-54. DOI ScienceOn |
4 | Cochrane DR, Howe EN, Spoelstra NS, Richer JK (2010). Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers. J Oncol, 56, 8217-27. |
5 | Bushati N, Cohen SM (2007). microRNA functions. Annu Rev Cell Dev Biol, 23, 175-205. DOI ScienceOn |
6 | Chakrabarti M, Banik NL, Ray SK (2013). miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis inneuroblastoma in vitro and in vivo. Exp Cell Res, 19, 1575-85. |
7 | Chen X, Pan M, Han L, et al (2013). miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a. FEBS Lett, 587, 3729-37. DOI |
8 | Davis BN, Hata A (2010). microRNA in Cancer The involvement of aberrant microRNA biogenesis regulatory pathways. Genes Cancer, 1, 1100-14. DOI |
9 | Dykxhoorn DM, Wu Y, Xie H, et al (2009). miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One, 4, 7181. DOI |
10 | Eckert D, Buhl S, Weber S, Jager R, Schorle H (2005). The AP-2 family of transcription factors. Genome Biol, 6, 213-46. DOI |
11 | Gabriely G, Yi M, Narayan RS, et al (2011). Human glioma growth is controlled by microRNA-10b. Cancer Res, 71, 3563-72. DOI |
12 | Gee JM, Eloranta JJ, Ibbitt JC, et al (2009). Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival. J PathoL, 217, 32-41. DOI |
13 | Gregory PA, Bert AG, Paterson EL, et al (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10, 593-601. DOI ScienceOn |
14 | Kong D, Li Y, Wang Z, et al (2009). miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells, 27, 1712-21. DOI ScienceOn |
15 | Guo JX, Tao QS, Lou PR, et al (2012). miR-181b as a potential molecular target for anticancer therapy of gastric neoplasms. Asian Pac J Cancer Prev, 13, 2263-7. 과학기술학회마을 DOI |
16 | Hasleton MD, Ibbitt JC, Hurst HC (2003). Characterization of the human activator protein-2gamma (AP-2gamma) gene: control of expression by Sp1/Sp3 inbreast tumour cells.Biochem J, 373, 925-32. DOI |
17 | Li Y, VandenBoom TG, Kong D, et al (2009). Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res, 69, 6704-12. DOI ScienceOn |
18 | Huang F, Lin C, Shi YH, Kuerban G. (2013). MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in hela cervical carcinoma cells. Asian Pac J Cancer Prev, 14, 5915-20. 과학기술학회마을 DOI ScienceOn |
19 | Korpal M, Kang Y (2008). The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol, 5, 115-9. DOI |
20 | Lee JW, Park YA, Choi JJ, et al (2011). The expression of the miRNA-200 family in endometrial endometrioid carcinoma.Gynecol Oncol, 120, 56-62. DOI ScienceOn |
21 | Liu Y, Liu Q, Jia W, et al (2013). MicroRNA-200a regulates Grb2 and suppresses differentiation of mouse embryonic stem cells into endoderm and mesoderm. PLoS One, 8, 68990. DOI |
22 | Lynch J, Fay J, Meehan M, et al (2012). MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF- signalling pathway. Carcinogenesis, 33, 976-85. DOI |
23 | Paterson EL, Kazenwadel J, Bert AG, et al (2013). Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. Neoplasia, 15, 180-91. DOI |
24 | McPherson JD, Apostol B, Wagner-McPherson CB, et al (1997). Radiation hybrid map of human chromosome 5 with integration of cytogenetic, genetic, and transcript maps.Genome Res, 7, 897-909. |
25 | Perissi V, Menini N, Cottone E, et al (2000). AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen. Oncogene, 19, 280-8. DOI ScienceOn |
26 | Osella-Abate S, Novelli M, Quaglino P, et al (2012). Expression of AP-2, AP-2 and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value. J Dermatol Sci, 68, 202-4. DOI |
27 | Park SM, Gaur AB, Lengyel E, Peter ME (2008). The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev, 22, 894-907. DOI ScienceOn |
28 | Pellikainen JM, Kosma VM (2007). Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review. Int J Cancer, 120, 2061-67. DOI |
29 | Qiao J, Lee S, Paul P, et al (2013). miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis.Surgery, 154, 226-33. DOI |
30 | Saydam O, Shen Y, Wurdinger T, et al (2009). Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol, 29, 5923-40. DOI ScienceOn |
31 | Soubani O, Ali AS, Logna F, et al (2012). Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis, 33, 1563-71. DOI |
32 | Uhlmann S, Zhang JD, Schwager A, et al (2010). miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion thanmiR-200a/141 in breast cancer. Oncogene, 29, 4297-306. DOI |
33 | Williams CM, Scibetta AG, Friedrich JK, et al (2009). AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene. EMBO J, 28, 3591-601. DOI |
34 | Stratmann J, Wang CJ, Gnosa S, et al (2011). Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer, 11, 345-54. DOI |
35 | Su J, Zhang A, Shi Z, et al (2012). MicroRNA-200a suppresses the Wnt/-catenin signaling pathway by interacting with -catenin. Int J Oncol, 40, 1162-70. |
36 | Uhlmann S, Zhang JD, Schwager A, et al (2010). miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene, 29, 4297-306. DOI |
37 | Yu Y, Wu J, Guan L, et al (2013). Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene family. Int J Cancer, 133, 1368-79. DOI |
38 | Du Y, Xu Y, Ding L, et al (2009). Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol, 44, 556-61. DOI |
39 | Woodfield GW, Horan AD, Chen Y, Weigel RJ (2007). TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling. Cancer Res, 67, 8439-43. DOI |